Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Randomized Study of Efficacy and Safety of Testosterone in Metastatic Renal Cell Carcinoma Patients With Fatigue

NCT03379012 is registered in ClinicalTrials.gov with Kidney Cancer Research Bureau as lead sponsor.

NCT NCT03379012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03379012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Randomized Study of Efficacy and Safety of Testosterone in Metastatic Renal Cell Carcinoma Patients With Fatigue
Lead sponsor
Kidney Cancer Research Bureau
Phase
Phase 2
Overall status
Completed
Start date
February 8, 2016
Completion date
July 30, 2019
Enrollment
60 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic renal cell carcinoma